Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model.
about
Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvementImmunomodulatory Role of Mesenchymal Stem Cell Therapy in Vascularized Composite AllotransplantationMesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin woundsHuman Adipose Stromal/Stem Cells from Obese Donors Show Reduced Efficacy in Halting Disease Progression in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell agingChanges in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?Interleukin 6 mediates the therapeutic effects of adipose-derived stromal/stem cells in lipopolysaccharide-induced acute lung injuryMesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE)Differential effects of culture senescence and mechanical stimulation on the proliferation and leiomyogenic differentiation of MSC from different sources: implications for engineering vascular grafts.Adipose stromal cells repair pressure ulcers in both young and elderly mice: potential role of adipogenesis in skin repair.Magnetofection Mediated Transient NANOG Overexpression Enhances Proliferation and Myogenic Differentiation of Human Hair Follicle Derived Mesenchymal Stem Cells.Are They Really Stem Cells? Scrutinizing the Identity of Cells and the Quality of Reporting in the Use of Adipose Tissue-Derived Stem Cells.Regenerative Potential of Mesenchymal Stromal Cells: Age-Related Changes.Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues.ADSC therapy in neurodegenerative disorders.Extracellular vesicles: potential roles in regenerative medicineStem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?Microenvironmental Views on Mesenchymal Stem Cell Differentiation in Aging.Adipose Stromal Vascular Fraction-Mediated Improvements at Late-Stage Disease in a Murine Model of Multiple Sclerosis.Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration.Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis.NANOG Restores Contractility of Mesenchymal Stem Cell-Based Senescent Microtissues.Comparison of proliferative and immunomodulatory potential of adipose-derived mesenchymal stem cells from young and geriatric cats.The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review
P2860
Q26860340-CC7CB8DC-FD05-41AB-B600-BC18C63C83D1Q28067456-0C7663F9-9E08-420A-AD1B-38ED4CABC737Q28085040-7476BAB0-A10B-490D-AD88-A44659380CC0Q30731580-435FEBFC-6324-49A7-9812-5F690175F854Q33999152-4FCBD039-CC42-4015-9949-A8ED6A07972AQ34803754-B67B49FF-4F70-4A43-9AA9-15707ED78107Q35195085-C6ECF1C5-13AB-4EC1-A397-E34A188AD705Q35213818-0256FC23-2F79-40F4-B25A-F573D7C86900Q35386693-F59DD2D6-F022-4825-982F-0A2BAB50BE44Q35665307-2493A44C-72E1-4C31-82D8-E7B41E90A09FQ36225105-9B4AFE3D-B708-4CD6-AB9F-FB3CFE1756CEQ36427302-20F64573-2E0B-4FDD-95B3-2F8CFE01D1A8Q36924909-E94CDFD0-C703-479D-8C1B-A107FB7C4144Q37071194-AA511983-7356-4F16-B7F0-6022302EBD5DQ38210872-32DA3169-3AFD-4D1F-AA42-548883002EB0Q38292668-614C2178-DE5D-46D7-952F-48C6D3A5E25CQ38341972-3CE601A6-3A96-47DC-82B3-9FE5295B85BCQ38865555-B4B73200-B734-43EB-9D45-FAFF4BFD504CQ39298794-948F77E8-C452-4623-815B-DB559F9C1698Q48117296-B4DD0DCE-95DB-40B3-9D70-542636CF5527Q49343380-673E198B-B72D-49AD-931C-4F0947934036Q51028000-76C5F500-45BE-40E8-A6D6-964DD767410CQ51030331-716F3B1C-0542-437D-99FA-6936C9374100Q57538743-9B803BE4-FC5E-49A5-9DED-21B0CEDA9F3B
P2860
Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Age of the donor reduces the a ...... encephalomyelitis mouse model.
@en
Age of the donor reduces the a ...... encephalomyelitis mouse model.
@nl
type
label
Age of the donor reduces the a ...... encephalomyelitis mouse model.
@en
Age of the donor reduces the a ...... encephalomyelitis mouse model.
@nl
prefLabel
Age of the donor reduces the a ...... encephalomyelitis mouse model.
@en
Age of the donor reduces the a ...... encephalomyelitis mouse model.
@nl
P2093
P2860
P356
P1476
Age of the donor reduces the a ...... encephalomyelitis mouse model.
@en
P2093
Allan V Kalueff
Amitabh C Pandey
Annie C Bowles
Brittni A Scruggs
Jeffrey M Gimble
Julie A Semon
Kathleen M P Imhof
Shijia Zhang
Xiujuan Zhang
P2860
P304
P356
10.5966/SCTM.2013-0026
P577
2013-09-09T00:00:00Z